Cell Systems News

Cell Systems
Introducing OptiCulture™ Serum-Free Medium: The New Standard for Precision in Human-Relevant Modeling

Introducing OptiCulture™ Serum-Free Medium: The New Standard for Precision in Human-Relevant Modeling

Redefine precision in your lab. Explore the new OptiCulture™ Serum-Free series from Cell Systems - specialized, and chemically defined media optimized for high-integrity barrier models and translational consistency.

Read more →


Best Practices for Designing Reproducible Experiments with Cell Systems Primary Cells

Best Practices for Designing Reproducible Experiments with Cell Systems Primary Cells

Turn good experiments into great ones. In this article, we share best practices on choosing the right endothelial cells, selecting assay-appropriate media and coatings, and optimizing seeding density to improve reproducibility and translational impact.

Read more →


Jesse Damm
AnaBios Acquires Cell Systems, Expands Human Cell Portfolio for Drug Discovery

AnaBios Acquires Cell Systems, Expands Human Cell Portfolio for Drug Discovery

AnaBios Corporation today announced the acquisition of Cell Systems, a human primary cell and cell culture media company located in Kirkland, Washington. 

Read more →


Microfluidic Device from Primary Human Cells Sheds Light on Cancer Mechanism

Microfluidic Device from Primary Human Cells Sheds Light on Cancer Mechanism

3D models are often applauded for being more predictive than 2D cultures, but not all scientists know how to maximize their 3D models’ biological relevance to reach their full potential. Using primary human cells (derived directly from human tissues) can greatly enhance the biological relevance of your models and steer your experiments in the right direction from the start. In a study by Kim et al., researchers use primary liver sinusoidal endothelial cells (Cat# ACBRI 566) to construct a 3D microfluidic human liver-chip to better understand how breast cancer-derived extracellular vehicles (EVs) can influence metastasis in the liver.

Read more →